Clinical Scorecard: Medical Oddities: When orgasm sets off the immune system
At a Glance
| Category | Detail |
|---|---|
| Condition | Post-orgasmic illness syndrome (POIS) |
| Key Mechanisms | Multisystem inflammatory response potentially involving mast cell activation and immune sensitization. |
| Target Population | Men and women experiencing symptoms following orgasm. |
| Care Setting | Clinical evaluation and management of post-orgasmic symptoms. |
Key Highlights
- POIS symptoms include fatigue, flu-like symptoms, brain fog, and mood changes.
- 88% of men with POIS had a positive skin response to their own semen.
- Treatment options include antihistamines, NSAIDs, corticosteroids, and omalizumab.
- Anticipation of symptoms may prime stress and inflammatory pathways.
- Controlled studies are needed to clarify biology and treatment responses.
Guideline-Based Recommendations
Diagnosis
- Clinical assessment based on symptomatology and patient history.
Management
- Consider antihistamines, NSAIDs, corticosteroids, and autologous semen desensitization.
Monitoring & Follow-up
- Monitor symptom response to treatments and potential side effects.
Risks
- Limited treatment evidence and variability in patient responses.
Patient & Prescribing Data
Individuals with POIS symptoms post-orgasm.
Omalizumab has shown promising results in individual cases.
Clinical Best Practices
- Conduct thorough patient history and symptom evaluation.
- Explore various treatment options based on individual patient responses.
- Stay updated on emerging research and treatment modalities.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
